Search Results - "Samir, Dalia"

Refine Results
  1. 1

    Rosai-Dorfman disease: tumor biology, clinical features, pathology, and treatment by Dalia, Samir, Sagatys, Elizabeth, Sokol, Lubomir, Kubal, Timothy

    Published in Cancer control (01-10-2014)
    “…Rosai-Dorfman disease (RDD) is a rare, nonmalignant clinical entity characterized by a group of clinical symptoms and characteristic pathological features…”
    Get more information
    Journal Article
  2. 2

    Primary Gastric Lymphoma, Epidemiology, Clinical Diagnosis, and Treatment by Juárez-Salcedo, Luis Miguel, Sokol, Lubomir, Chavez, Julio C., Dalia, Samir

    Published in Cancer Control (01-01-2018)
    “…Primary gastric lymphoma (PGL) is the most common extranodal non-Hodgkin lymphoma and represents a wide spectrum of disease, ranging from indolent low-grade…”
    Get full text
    Book Review Journal Article
  3. 3

    Venetoclax: evidence to date and clinical potential by Juárez-Salcedo, Luis Miguel, Desai, Viraj, Dalia, Samir

    Published in Drugs in Context (09-10-2019)
    “…The emergence of targeted therapy for patients with hematological diseases has permanently altered the therapeutic landscape. Immunochemotherapy regimes are…”
    Get full text
    Journal Article
  4. 4

    Diffuse large B-cell lymphoma: current strategies and future directions by Cultrera, Jennifer L, Dalia, Samir M

    Published in Cancer control (01-07-2012)
    “…Diffuse large B-cell lymphoma (DLBCL) is the most common histology of non-Hodgkin lymphoma, representing 25% to 35% of new cases annually. The incidence of…”
    Get more information
    Journal Article
  5. 5

    Hepatitis B Reactivation in the Treatment of Non-Hodgkin Lymphoma by Kelling, Matthew, Sokol, Lubomir, Dalia, Samir

    Published in Cancer Control (01-01-2018)
    “…Chronic active hepatitis B infection (HBV) has been implicated in lymphomagenesis of non-Hodgkin lymphoma (NHL). Treatment of cancer including NHL with…”
    Get full text
    Book Review Journal Article
  6. 6

    Loncastuximab Tesirine in the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma by Juárez-Salcedo, Luis Miguel, Nimkar, Santosh, Corazón, Ana María, Dalia, Samir

    “…Currently, a significant percentage of patients with DLBCL are refractory or relapse after a first line of immunochemotherapy. Second relapses after autologous…”
    Get full text
    Journal Article
  7. 7

    Dendritic cell and histiocytic neoplasms: biology, diagnosis, and treatment by Dalia, Samir, Shao, Haipeng, Sagatys, Elizabeth, Cualing, Hernani, Sokol, Lubomir

    Published in Cancer control (01-10-2014)
    “…Dendritic and histiocytic cell neoplasms are rare malignancies that make up less than 1% of all neoplasms arising in lymph nodes or soft tissues. These…”
    Get more information
    Journal Article
  8. 8

    Hepatitis B infection increases the risk of non-Hodgkin lymphoma: A meta-analysis of observational studies by Dalia, Samir, Chavez, Julio, Castillo, Jorge J, Sokol, Lubomir

    Published in Leukemia research (01-09-2013)
    “…Abstract Hepatitis B virus (HBV) infection is a major public health problem and the association between HBV infection and non-Hodgkin lymphoma (NHL) is…”
    Get full text
    Journal Article
  9. 9

    Clinicopathologic characteristics and outcomes of histiocytic and dendritic cell neoplasms: the moffitt cancer center experience over the last twenty five years by Dalia, Samir, Jaglal, Michael, Chervenick, Paul, Cualing, Hernani, Sokol, Lubomir

    Published in Cancers (14-11-2014)
    “…Neoplasms of histiocytic and dendritic cells are rare disorders of the lymph node and soft tissues. Because of this rarity, the corresponding biology,…”
    Get full text
    Journal Article
  10. 10

    Primary Mucosa-Associated Lymphoid Tissue Lymphoma of the Parotid Gland in 32-Year-Old Male, a Case Report by Glass, Bianca M., Al Jaberi, Mira, Irlam, John H., Dalia, Samir M.

    “…Primary lymphomas of the salivary gland are rare. The most common subtype is MALT lymphoma. MALT lymphoma has an indolent clinical course, and patients often…”
    Get full text
    Journal Article
  11. 11

    Progressive Multifocal Leukoencephalopathy and Monoclonal Antibodies by Bohra Chandrashekar, Sokol Lubomir, Samir, Dalia

    Published in Cancer control (01-11-2017)
    “…Progressive multifocal leukoencephalopathy (PML) is a viral infection predominantly seen in patients with HIV infection. However, with the increased use of…”
    Get full text
    Journal Article
  12. 12

    Management of adverse effects of new monoclonal antibody treatments in acute lymphoblastic leukemia by Conde-Royo, Diego, Juárez-Salcedo, Luis Miguel, Dalia, Samir

    Published in Drugs in Context (14-10-2020)
    “…Therapeutic options for relapsed/refractory B-cell acute lymphoblastic leukemia have evolved in the past few years. The FDA has approved three novel therapies…”
    Get full text
    Journal Article
  13. 13

    Review of Peripheral Blood Eosinophilia: Workup and Differential Diagnosis by Weaver, Michael Dennis, Glass, Bianca, Aplanalp, Chance, Patel, Gauri, Mazhil, Jeshrine, Wang, Isabella, Dalia, Samir

    Published in Hemato (01-03-2024)
    “…Eosinophils are a type of granulocyte key to immune system modulation seen in a number of disease processes. Nearly every major organ system can be connected…”
    Get full text
    Journal Article
  14. 14

    Meta-Analysis of the Association Between Cigarette Smoking and Incidence of Hodgkin's Lymphoma by CASTILLO, Jorge J, DALIA, Samir, SHUM, Helen

    Published in Journal of clinical oncology (10-10-2011)
    “…Previous studies have suggested a relationship between smoking and Hodgkin's lymphoma (HL). The main objective of this study was to evaluate this potential…”
    Get full text
    Journal Article
  15. 15

    Financial Hardship Among Patients With Early-Stage Colorectal Cancer by Sadigh, Gelareh, Duan, Fenghai, An, Na, Gareen, Ilana D, Sicks, JoRean, Suga, Jennifer M, Kehn, Heather, Mehan, Paul T, Bajaj, Rajesh, Hanson, David S, Dalia, Samir M, Acoba, Jared D, Yasar, Demet GoKalp, Taylor, Michael A, Park, Elyse, Wagner, Lynne I, Kircher, Sheetal M, Carlos, Ruth C

    Published in JAMA network open (03-09-2024)
    “…The degree of cancer patients' financial hardship is dynamic and can change over time. To assess longitudinal changes in financial hardship among patients with…”
    Get full text
    Journal Article
  16. 16

    The m6A methyltransferase WTAP plays a key role in the development of diffuse large B-cell lymphoma via regulating the m6A modification of catenin beta 1 by Guo, Shuangshuang, Zhao, Chunling, Fang, Liang, Xu, Wenzhong, Dalia, Samir, Glass, Jon, Shikama, Naoto, Zhang, Zhiye

    Published in Annals of translational medicine (01-07-2022)
    “…BackgroundDiffuse large B-cell lymphoma (DLBCL) is the most frequently occurring subtype of lymphoma. Unfortunately, the fundamental processes underlying the…”
    Get full text
    Journal Article
  17. 17

    Patient-Reported Financial Burden of Treatment for Colon or Rectal Cancer by Kircher, Sheetal, Duan, Fenghai, An, Na, Gareen, Ilanan F, Sicks, JoRean D, Sadigh, Gelareh, Suga, Jennifer M, Kehn, Heather, Mehan, Paul T, Bajaj, Rajesh, Hanson, David S, Dalia, Samir M, Acoba, Jared D, Yasar, Demet Gokalp, Park, Elyse R, Wagner, Lynne I, Carlos, Ruth C

    Published in JAMA network open (02-01-2024)
    “…The longitudinal experience of patients is critical to the development of interventions to identify and reduce financial hardship. To evaluate financial…”
    Get full text
    Journal Article
  18. 18

    Tetraploidy acute promyelocytic leuemia with double t(15;17)/PML-RARA, a case report with review of literature by Dalia, Samir M, Horna, Pedro, Zhang, Ling

    “…Acute promyelocytic leukemia (APL) with tetraploidy chromosome harboring t(15;17)(q23;a21) is extremely rare. To date, there are 14 such cases reports that…”
    Get full text
    Journal Article
  19. 19

    Use of anti-CD20 therapy in follicular and marginal zone lymphoma: a review of the literature by Juárez-Salcedo, Luis Miguel, Conde-Royo, Diego, Quiroz-Cervantes, Keina, Dalia, Samir

    Published in Drugs in Context (2020)
    “…The identification of the CD20 antigen in 1979 was the first step in what would become a therapeutic milestone opening the use of immunotherapy in…”
    Get full text
    Journal Article
  20. 20

    Hepatitis B Reactivation with Novel Agents in Non-Hodgkin's Lymphoma and Prevention Strategies by Ozoya, Oluwatobi O, Sokol, Lubomir, Dalia, Samir

    “…Hepatitis B virus (HBV) infection remains an endemic disease in most parts of the world despite available prophylactic vaccines. Non-Hodgkin's lymphoma is the…”
    Get full text
    Journal Article